In The News Posted September 4, 2019 Share Posted September 4, 2019 SANA'A, Yemen, Sept. 4, 2019 /PRNewswire/ -- MSD (trade name of Merck & Co., Inc., Kenilworth, N.J., USA), GSK, and the Mectizan Donation Program congratulate the government, and the people of Yemen for receiving validation by the World Health Organization (WHO) for eliminating lymphatic... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.